Enter your Email address:
Wolters Kluwer Health may email you for journal alerts and information, but is committed
to maintaining your privacy and will not share your personal information without
You currently have no recent searches
Park, Sung Chul MD*,†
*Department of Ophthalmology, New York Medical College
†Moise and Chella Safra Advanced Ocular Imaging Laboratory, New York Eye & Ear Infirmary, New York, NY
Disclosure: The author declares no conflict of interest.
Glaucoma is a progressive optic neuropathy characterized by a particular pattern of optic disc changes and visual field loss. It has traditionally been considered a disease limited to the eye. However, the retina and optic nerve are part of the central nervous system and we now know that retinal ganglion cell loss in glaucoma is associated with damage in the central nervous system including the lateral geniculate nucleus and visual cortex.1,2 In addition, the trans-lamina cribrosa pressure difference and gradient as well as the stasis of cerebrospinal fluid (CSF) in the peripapillary area have been implicated in the pathogenesis of glaucoma.3–7
This supplement represents the proceedings of the 18th annual Optic Nerve Rescue and Restoration Think Tank, sponsored by The Glaucoma Foundation, entitled ‘Glaucoma and the Central Nervous System’ and held in New York, NY, September 16-17, 2011. The goal of The Glaucoma Foundation Think Tank is to explore areas of future medical or scientific interest by involving clinician-scientists, researchers in glaucoma, researchers in other areas of ophthalmology, and potential collaborators currently not involved in vision research in order to promote innovation and to identify important areas for future research and funding. Potential applications to eye disease with particular attention to prevention and reversal of blindness are our ultimate focus.
Ocular hypotensive therapy, which is the only approved form of glaucoma treatment, can slow disease progression but is often insufficient to stop further visual loss.8 Experts’ opinions described in this article on the relevant anatomy, physiology, and pathology of the central nervous system and cerebrospinal fluid dynamics shed light on the development of the diagnostics and therapeutics of glaucoma as a degenerative disease of the central nervous system.
Copyright © 2013 by Lippincott Williams & Wilkins
Colleague's E-mail is Invalid
Your Name: (optional)
Separate multiple e-mails with a (;).
Thought you might appreciate this item(s) I saw at Journal of Glaucoma.
Send a copy to your email
Your message has been successfully sent to your colleague.
Some error has occurred while processing your request. Please try after some time.
An Existing Folder
A New Folder
The item(s) has been successfully added to "".
Login with your LWW Journals username and password.
Username or Email:
Enter and submit the email address you registered with. An email with instructions to reset your password will be sent to that address.
Link to reset your password has been sent to specified email address.
What does "Remember me" mean?
By checking this box, you'll stay logged in until you logout. You'll get easier access to your articles, collections,
media, and all your other content, even if you close your browser or shut down your
To protect your most sensitive data and activities (like changing your password),
we'll ask you to re-enter your password when you access these services.
What if I'm on a computer that I share with others?
If you're using a public computer or you share this computer with others, we recommend
that you uncheck the "Remember me" box.
Save my selection